UCSF Memory and Aging Center UCSF About UCSF Search UCSF UCSF Medical Center UCSF Memory and Aging Center Alzheimer's Disease Research Center Home Contact Us Make A Gift Sitemap
Clinic Education Research Caregivers Professional Training Events Resources Staff Art In Chinese En Espanol UCSF Memory and Aging Center

Research
Introduction
MAC Research
ADRC Research
Autopsy Program
Healthy Volunteering
Investigator Requests


Observational Studies             Treatment Trials

Frontotemporal Dementia: Genes, Images and Emotions

Study Director Bruce Miller, MD
Sponsor National Institute on Aging
Recruiting? Yes
Official Study Title Frontotemporal Dementia: Genes, Images and Emotions
Conditions Studied

Frontotempora Dementia (FTD)
Semantic Dementia (SD)
Primary Progressive Aphasia (PPA)
Frontotemporal Dementia with Amyotrophic Lateral Sclerosis (FTD-ALS)
Corticobasal Degeneration (CBD)
Progressive Supranuclear Palsy (PSP)
Alzheimer's Disease (AD)
Amyotrophic Lateral Sclerosis (ALS)
Healthy Aging

Purpose The purpose of this study is to help understand the clinical, genetic, imaging, emotional and diagnostic features of frontotemporal lobar degeneration (FTLD), also referred to as frontotemporal dementia or Pick's disease. The study will collect longitudinal clinical, imaging, behavioral and autopsy data to be analyzed with the goal of improving clinical care for patients with FTLD.
Eligibility  
Inclusion Criteria Participants must be between the ages of 35 and 80 and meet criteria for either the FTLD, PSP, CBD, AD, ALS or healthy aging group. Participants will need a reliable study partner who has frequent contact with the participant, is available to provide inforamtion about the participant, and who can accompany the participant to research visits as needed. Participants must be willing and able to have brain MRIs through the course of the study and have an MMSE score of 15 or greater at time of screening. Anyone not meeting these criteria will need to be approved by the Study Director.
Exclusion Criteria The exclusion criteria include:
  • A history of Korsakoff encephalopathy, alcohol abuse or dependence within 5 years of the onset of dementia, substance abuse, head trauma with a loss of consciousness greater than 30 minutes, brain tumor, multiple sclerosis, epilepsy, Parkinson's disease, communicating or non-communicating hydrocepalus, schizophrenia, bipolar affective disorder, intracerebral hemmorrhage
  • B12 deficiency, hypothyroidism, HIV positive, renal failure, liver failure, repiratory failure requiring oxygen, dementia due to a condition other than those described above, cerebral infarct, large white matter lesions, significant systemic medical illness. Current medication likely to affect CNS functions: benzodiazepines more than three times weekly, no diazepam or triazolam but other short-acting benzodiazepines are fine; no amitriptyline or doxepin, SSRIs and other tricyclics are fine; no lithium; no neuroleptics in the phenothiazine or haloperidol families; no narcotics, codeine is fine but cannot be taken for 24 hours prior to cognitive testing; no anticonvulsants outside therapuetic ranges; and no antihistamines taken more than three times weekly, cannot be taken for 24 hours prior to cognitive testing.
What is Involved?  
Testing Neurological and physical examinations; interivew with study partner; MRIs; cognitive testing; detailed family history; blood specimen collection for genetic testing and cell line gerneration; behavioral, emotional, and personality testing; questionnaires for participant and study partner; pre-conset to obtain a brain autopsy. Participants will be asked to participate in additonal studies affiliated with this project.
Frequency of Visits Depending on the individual, there will be 4 to 6 visits over a three month period of time, each year for up to five years. Participants may choose to participate as an inpatient, staying in Moffitt Hospital in the General Clincal Research Center, and compelte the visits in one week or as an outpatient and spread the visits out over three months.
Contact Information  
Coordinator Robin Ketelle RN, MS
Phone (415) 514-2058
Materials Needed Prior to Evaluation MRI scan and medical records
Costs There are no costs associated with the evaluations that happen as part of this study. For those who choose to stay in the hospital, there are no costs associated with the stay. Parking in the Millberry garage will be reimbursed. Participants are responsible for their travel and hotel, should they choose to stay in one.

Back to Top

350 Parnassus Avenue, Suite 905 • San Francisco, California 94117 • (415) 476-6880
© 2008 The Regents of the University of California